Both LSPR and AFM have high sensitivity and specificity, and can detect and quantify raised levels of CD44 and CD133 in immunocaptured glioma-derived exosomes in the blood and CSF of animal models (72). The gene discussed is CD44; the disease is central nervous system cancer.